Search Results
Dr. Moore on Benefit of Mirvetuximab Soravtansine in Patients With Ovarian Cancer
Dr. Moore on the Role of Mirvetuximab Soravtansine in Ovarian Cancer
Dr. Moore on Early-Phase Data With Mirvetuximab Soravtansine in Ovarian Cancer
Dr. Moore on Safety Profile of Mirvetuximab Soravtansine in Ovarian Cancer
An Overview of a Study Exploring Mirvetuximab Soravtansine in Ovarian Cancer
Dr. Moore on Anticipated Impact of the MIRASOL Trial in Platinum-Resistant Ovarian Cancer
Mirvetuximab Soravtansine Remains Well Tolerated in Platinum-Resistant Ovarian Cancer
Dr. O’Malley on the Safety Profile of Mirvetuximab in Ovarian Cancer
Dr. Moore Discusses Combinations in Ovarian Cancer
Dr. English on Mirvetuximab Soravtansine in Ovarian Cancer
Results for Combination Bevacizumab Plus Mirvetuximab Soravtansine in Ovarian Cancer
Mirvetuximab Soravtansine Combination Improves Responses in Platinum-Agnostic Ovarian Cancer
